A detailed history of Gladstone Institutional Advisory LLC transactions in Amgen Inc stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 5,942 shares of AMGN stock, worth $1.75 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,942
Previous 4,948 20.09%
Holding current value
$1.75 Million
Previous $1.55 Million 23.8%
% of portfolio
0.1%
Previous 0.08%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$309.38 - $337.38 $307,523 - $335,355
994 Added 20.09%
5,942 $1.91 Million
Q2 2024

Aug 02, 2024

BUY
$262.75 - $319.31 $8,408 - $10,217
32 Added 0.65%
4,948 $1.55 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $909,856 - $1.1 Million
-3,384 Reduced 40.77%
4,916 $1.4 Million
Q4 2023

Feb 09, 2024

BUY
$255.7 - $288.46 $114,809 - $129,518
449 Added 5.72%
8,300 $2.39 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $66,032 - $81,980
-302 Reduced 3.7%
7,851 $2.11 Million
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $500,106 - $591,365
-2,334 Reduced 22.26%
8,153 $1.81 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $76,542 - $93,292
-339 Reduced 3.13%
10,487 $2.54 Million
Q4 2022

Feb 01, 2023

BUY
$229.03 - $291.01 $1.32 Million - $1.68 Million
5,767 Added 113.99%
10,826 $2.84 Million
Q3 2022

Jan 27, 2023

SELL
$224.46 - $253.15 $61,053 - $68,856
-272 Reduced 5.1%
5,059 $1.14 Million
Q3 2022

Oct 20, 2022

SELL
$224.46 - $253.15 $61,053 - $68,856
-272 Reduced 5.1%
5,059 $1.14 Million
Q2 2022

Jan 27, 2023

SELL
$230.71 - $256.74 $478,492 - $532,478
-2,074 Reduced 28.01%
5,331 $1.3 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $478,492 - $532,478
-2,074 Reduced 28.01%
5,331 $1.3 Million
Q1 2022

Jan 27, 2023

SELL
$219.27 - $242.57 $314,433 - $347,845
-1,434 Reduced 16.22%
7,405 $1.79 Million
Q1 2022

May 04, 2022

SELL
$219.27 - $242.57 $314,433 - $347,845
-1,434 Reduced 16.22%
7,405 $1.79 Million
Q4 2021

Jan 27, 2023

BUY
$198.88 - $227.6 $208,227 - $238,297
1,047 Added 13.44%
8,839 $1.99 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $208,227 - $238,297
1,047 Added 13.44%
8,839 $1.99 Million
Q3 2021

Jan 27, 2023

BUY
$212.27 - $248.7 $341,330 - $399,909
1,608 Added 26.0%
7,792 $1.66 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $341,330 - $399,909
1,608 Added 26.0%
7,792 $1.66 Million
Q2 2021

Jan 27, 2023

BUY
$233.58 - $259.14 $584,650 - $648,627
2,503 Added 68.0%
6,184 $1.51 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $584,650 - $648,627
2,503 Added 68.0%
6,184 $1.51 Million
Q1 2021

Jan 27, 2023

BUY
$221.91 - $258.6 $526,370 - $613,399
2,372 Added 181.21%
3,681 $916,000
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $526,370 - $613,399
2,372 Added 181.21%
3,681 $916,000
Q4 2020

Jan 27, 2023

SELL
$216.38 - $257.67 $22,719 - $27,055
-105 Reduced 7.43%
1,309 $301,000
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $22,719 - $27,055
-105 Reduced 7.43%
1,309 $301,000
Q3 2020

Jan 27, 2023

SELL
$234.65 - $260.95 $855,299 - $951,162
-3,645 Reduced 72.05%
1,414 $359,000
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $42,940 - $47,753
183 Added 14.87%
1,414 $359,000
Q2 2020

Aug 17, 2020

SELL
$197.81 - $242.74 $62,507 - $76,705
-316 Reduced 20.43%
1,231 $290,000
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $34,990 - $46,406
-192 Reduced 11.04%
1,547 $314,000
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $20,813 - $26,752
-110 Reduced 5.95%
1,739 $419,000
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $45,094 - $54,032
-259 Reduced 12.29%
1,849 $358,000
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $106,187 - $124,476
637 Added 43.3%
2,108 $389,000
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $28,577 - $32,213
-158 Reduced 9.7%
1,471 $279,000
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $290,613 - $339,239
1,629 New
1,629 $317,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.